Nucleic Acid Leader Bio-Synthesis specializes in custom oligonucleotide and nucleic acid technologies, including Bridged Nucleic Acids, offering advanced synthesis capabilities that can support clients needing stable, high-affinity nucleic acid constructs for diagnostics and therapeutics.

Peptide Expertise With extensive experience in custom peptide synthesis, including long, complex, and hydrophobic sequences and multiple modification options, Bio-Synthesis can fulfill peptide API and library needs for drug discovery, diagnostics, and therapeutic applications.

Quality and Compliance Operating an ISO 9001 certified facility with 21 CFR 210/211 and 21 CFR 820 compliance, Bio-Synthesis presents a reputable, regulated partner suitable for projects requiring strict quality and regulatory alignment.

Boutique Scale Advantage Small-to-mid sized employee base (11-50) and revenue in the mid-range suggest agility and personalized service, making Bio-Synthesis an attractive contract manufacturing option for mid-size biotech firms seeking reliable plasmid/oligo and peptide supply without large-entity overhead.

Expansion Opportunity Founded in 1984 with a history of pioneering oligonucleotide techniques and BNA technology licensing, there is potential to upsell licensing, collaboration on novel nucleic acid chemistries, and expanded custom synthesis services to researchers and diagnostic developers looking for cutting-edge materials.